IL33 and Myocardial fibrosis: At the cardiac level, the ST2L/IL-33 interaction initiates a complex cardioprotective biochemical cascade, which prevents cardiomyocyte hypertrophy, apoptosis, and myocardial fibrosis, thereby improving cardiac function.